Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
×
In this paper we propose a knowledge-based BC treatment effects and complication infrastructure (BCTECI) approach to reason and appraise the effectiveness of BC ...
Based on these conditions and advances in cancer research and the treatment status of bladder malignancies, we propose to create a knowledge-based BC treatment ...
Jan 14, 2022 · This paper presents a new approach, founded on evidence-based medical knowledge, using as much information and proof as possible to help a ...
People also ask
May 22, 2024 · Study results also highlighted a 55% reduction in disease progression or death compared to treatment with cisplatin-based chemotherapy, making ...
Missing: knowledge- evidence
This review presents the current status of diagnostic and treatment options in bladder cancer (BCa) patients with clinically positive lymph nodes (cN+).
Predicting potential cancer treatment side effects at time of prescription could decrease potential health risks and achieve better patient satisfaction.
Oct 4, 2019 · Phase III clinical trials of neoadjuvant cisplatin-based chemotherapy have demonstrated a survival benefit in patients with MIBC, mainly by ...
Missing: evidence | Show results with:evidence
May 1, 2024 · Because these cancers are hard to cure with current treatments, many experts recommend considering taking part in a clinical trial that's ...
Nov 30, 2023 · Overall, tumors shrank or stopped growing in about 67% of participants treated with enfortumab plus pembrolizumab, compared with 44% of those ...
Missing: Reasoning approach.
Aug 19, 2021 · Results from the study presented 80.3% of real reported bladder cancer treatment side-effects prediction and were close to really occurring ...